| 摘要 |
A method for treating mild dysplasia of cervix uteri (CIN I) caused by papilloma virus comprises the oral use of biologically active additive based on indol-3-carbinol, one capsule twice a day for three months and immunomodulating therapy under periodical cytological control. For controlling the state of vaginal biocenosis, polymerase chain reaction in real time is used with test reagents Femoflor. Galavit suppositories are used as immunomodulating agent, 100 µg per rectum before the night sleep for 10 days. Fermalak vaginal suppositories are used as bacterial biological preparation, one suppository before the night sleep for 10 days. Cervarix vaccine is administered intramuscularly. |
